Logo for VistaGen Therapeutics Inc

VistaGen Therapeutics Inc Investor Relations Material

Latest events

Logo for VistaGen Therapeutics Inc

Q3 2024

VistaGen Therapeutics Inc
Logo for VistaGen Therapeutics Inc

Q3 2024

13 Feb, 2024
Logo for VistaGen Therapeutics Inc

Q2 2024

9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from VistaGen Therapeutics Inc

Access all reports
VistaGen Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). Our lead product candidate PH94B is a rapid-onset neuroactive nasal spray targeted at the treatment of anxiety.